The impact of age on morbidity and mortality following esophagectomy for esophageal cancer

Cancer Control

Volumn 20, Issue 2, 2013, Pages 144-150

  McLoughlin, James M ^a   Lewis, James M ^a   Meredith, Kenneth L ^b  

^a UNIVERSITY OF TENNESSEE   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE OUTCOME; AGE; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER SURVIVAL; COMORBIDITY; DATA ANALYSIS; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FUNCTIONAL STATUS; HOSPITALIZATION; HUMAN; MINIMAL RESIDUAL DISEASE; MORBIDITY; PATIENT CARE; POSTOPERATIVE COMPLICATION; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURGICAL MORBIDITY; SURGICAL MORTALITY; TREATMENT OUTCOME;

EID: 84875832089     PISSN: 10732748     EISSN: 15262359     Source Type: Journal    
DOI: 10.1177/107327481302000208     Document Type: Article

References (49)

1. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24(14):2137-2150.
2. Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst. 2005;97(2):142-146.
3. Brown LM, Devesa SS, Chow WH. Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst. 2008;100(16):1184-1187
4. Trivers KF, Sabatino SA, Stewart SL. Trends in esophageal cancer incidence by histology, United States, 1998-2003. Int J Cancer. 2008; 123(6):1422-1428.
5. El-Serag HB, Mason AC, Petersen N, et al. Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA. Gut. 2002;50(3):368-372.
6. Siegel R, Neishadham D, Jamal A. Cancer statistics, 2013. Ca Cancer J Clin. 2013;63(1):11-30.
7. Siegel R, Ward E, Brawley O, et al. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011;61(4):212-236.
8. Esophageal Incidence by Age. 1975-2008. http://seer.cancer.gov/csr/1975_2008/results_merged/sect_08_esophagus.pdf. Accessed February 28, 2013.
9. Nygaard K, Hagen S, Hansen HS, et al. Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg. 1992;16(6):1104-1110.
10. Pennathur A, Luketich JD, Landreneau RJ, et al. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm. Ann Thorac Surg. 2008;85(6):1930-1937.
11. Urba SG, Orringer MB, Turrisi A, et al. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol. 2001;19(2):305-313.
12. Urschel JD, Vasan H. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg. 2003;185(6):538-543.
13. Walsh TN, Noonan N, Hollywood D, et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med. 1996;335(7):462-467.
14. Rice TW, Rusch VW, Ishwaran H, et al. Cancer of the esophagus and esophagogastric junction: data-driven staging for the seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Cancer Staging Manuals. Cancer. 2010;116(16):3763-3773.
15. Ancona E, Ruol A, Santi S, et al. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone. Cancer. 2001;91(11):2165-2174.
16. Berger AC, Farma J, Scott WJ, et al. Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival. J Clin Oncol. 2005;23(19):4330-4337.
17. Hammoud ZT, Kesler KA, Ferguson MK, et al. Survival outcomes of resected patients who demonstrate a pathologic complete response after neoadjuvant chemoradiation therapy for locally advanced esophageal cancer. Dis Esophagus. 2006;19(2):69-72.
18. Meredith KL, Weber JM, Turaga KK, et al. Pathologic response after neoadjuvant therapy is the major determinant of survival in patients with esophageal cancer. Ann Surg Oncol. 2010;17(4):1159-1167.
19. Schwer AL, Ballonoff A, McCammon R, et al. Survival effect of neoadjuvant radiotherapy before esophagectomy for patients with esophageal cancer: a surveillance, epidemiology, and end-results study. Int J Radiat Oncol Biol Phys. 2009;73(2):449-455.
20. Bedenne L, Michel P, Bouche O, et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol. 2007;25(10):1160-1168.
21. Stahl M, Stuschke M, Lehmann N, et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol. 2005;23(10):2310-2317.
22. Arnott SJ, Duncan W, Gignoux M, et al. Preoperative radiotherapy in esophageal carcinoma: a meta-analysis using individual patient data (Oesophageal Cancer Collaborative Group). Int J Radiat Oncol Biol Phys. 1998;41(3):579-583.
23. Fiorica F, Di Bona D, Schepis F, et al. Preoperative chemoradiother- apy for oesophageal cancer: a systematic review and meta-analysis. Gut. 2004;53(7):925-930.
24. Kaklamanos IG, Walker GR, Ferry K, et al. Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: a meta-analysis of randomized clinical trials. Ann Surg Oncol. 2003;10(7): 754-761.
25. Gebski V, Burmeister B, Smithers BM, et al. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol. 2007;8(3):226-234.
26. Naunheim KS, Hanosh J, Zwischenberger J, et al. Esophagectomy in the septuagenarian. Ann Thorac Surg. 1993;56(4):880-884.
27. Ferguson MK, Martin TR, Reeder LB, et al. Mortality after esophagectomy: risk factor analysis. World J Surg. 1997;21(6):599-603.
28. Rice DC, Correa AM, Vaporciyan AA. Preoperative chemoradio- therapy prior to esophagectomy in elderly patients is not associated with increased morbidity. Ann Thorac Surg. 2005;79(2):391-397.
29. Smith GL, Smith BD, Buchholz TA, et al. Patterns of care and locore- gional treatment outcomes in older esophageal cancer patients: the SEER- Medicare Cohort. Int J Radiat Oncol Biol Phys. 2009;74(2):482-489.
30. Kiernan PD, Khandhar SJ, Fortes DL, et al. Thoracic surgery in octogenarians: CVTSA/Inova Fairfax hospital experience, 1990 to 2009. Am Surg. 2011;77(6):675-680.
31. Morita M, Egashira A, Yoshida R, et al. Esophagectomy in patients 80 years of age and older with carcinoma of the thoracic esophagus. J Gastroenterol. 2008;43(5):345-351.
32. Atkins BZ, Shah AS, Hutcheson KA, et al. Reducing hospital morbidity and mortality following esophagectomy. Ann Thorac Surg. 2004;78(4):1170-1176.
33. Fang W, Igaki H, Tachimori Y, et al. Three-field lymph node dissection for esophageal cancer in elderly patients over 70 years of age. Ann Thorac Surg. 2001;72(3):867-871.
34. Ellis FH Jr, Williamson WA, Heatley GJ. Cancer of the esophagus and cardia: does age influence treatment selection and surgical outcomes? J Am Coll Surg. 1998;187(4):345-351.
35. Alexiou C, Beggs D, Salama FD, et al. Surgery for esophageal cancer in elderly patients: the view from Nottingham. J Thorac Cardiovasc Surg. 1998;116(4):545-553.
36. Poon RT, Law SY, Chu KM, et al. Esophagectomy for carcinoma of the esophagus in the elderly: results of current surgical management. Ann Surg. 1998;227(3):357-364.
37. Jougon JB, Ballester M, Duffy J, et al. Esophagectomy for cancer in the patient aged 70 years and older. Ann Thorac Surg. 1997;63(5):1423-1427.
38. Thomas P Doddoli C, Neville P, et al. Esophageal cancer resection in the elderly. Eur J Cardiothorac Surg. 1996;10(11):941-946.
39. Moskovitz AH, Rizk NP, Venkatraman E, et al. Mortality increases for octogenarians undergoing esophagogastrectomy for esophageal cancer. Ann Thorac Surg. 2006;82(6):2031-2036.
40. Ruol A, Portale G, Zaninotto G, et al. Results of esophagectomy for esophageal cancer in elderly patients: age has little influence on outcome and survival. J Thorac Cardiovasc Surg. 2007;133(5):1186-1192.
41. Fogh SE, Yu A, Kubicek GJ, et al. Do elderly patients experience increased perioperative or postoperative morbidity or mortality when given neoadjuvant chemoradiation prior to esophagectomy? Int J Radiat Oncol Biol Phys. 2011;80(5):1372-1376.
42. Copeland GP, Jones D, Walters M. POSSUM: a scoring system for surgical audit. Br J Surg. 1991;78(3):355-360.
43. Whiteley MS, Prytherch DR, Higgins B, et al. An evaluation of the POSSUM surgical scoring system. Br J Surg. 1996;83(6):812-815.
44. Richards CH, Leitch FE, Horgan PG, et al. A systematic review of POSSUM and its related models as predictors of post-operative mortality and morbidity in patients undergoing surgery for colorectal cancer. J Gastro- intest Surg. 2010;14(10):1511-1520.
45. Tekkis PP, McCulloch P, Poloniecki JD, et al. Risk-adjusted prediction of operative mortality in oesophagogastric surgery with O-POSSUM. Br J Surg. 2004;91(3):288-295.
46. Bosch DJ, Pultrum BB, de Bock GH, et al. Comparison of different risk-adjustment models in assessing short-term surgical outcome after trans- thoracic esophagectomy in patients with esophageal cancer. Am J Surg. 2011;202(3):303-309.
47. Dhungel B, Diggs BS, Hunter JG, et al. Patient and peri-operative predictors of morbidity and mortality after esophagectomy: American College of Surgeons National Surgical Quality Improvement Program (ACS- NSQIP), 2005-2008. J Gastrointest Surg. 2010;14(10):1492-1501.
48. Ra J, Paulson EC, Kucharczuk J, et al. Postoperative mortality after esophagectomy for cancer: development of a preoperative risk prediction model. Ann Surg Oncol. 2008;15(6):1577-1584.
49. Zingg U, Langton C, Addison B, et al. Risk prediction scores for postoperative mortality after esophagectomy: validation of different models. J Gastrointest Surg. 2009;13(4):611-618.